Search

everythinglearnresearchcommunity

for

Search:↓

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

Lipid nanoparticles in cosmetics can effectively improve skin disorders and hair loss.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

A new method using nanolipogels with fucosterol can help regrow hair by targeting follicles, reducing inflammation, and improving blood flow.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Rebamipide may help regrow hair by activating hair follicle stem cells.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Low-dose naltrexone and platelet-rich plasma can regrow hair in lichen planopilaris.

Phosphatide distribution in mouse skin remains consistent in both normal and cancerous growths.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Low-dose naltrexone might be a cheap and effective additional treatment for hair loss with scalp discomfort due to its anti-inflammatory effects and few side effects.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

The treatment cleared psoriasis in some patients but caused side effects in most.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

GLPLS and LPP are variants of lichen planus.